Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.70123 | 29 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.6694 | 30 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.66993 | 29 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.58273 | 28 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.60413 | 28 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.78325 | 31 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.19637 | 48 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.63879 | 29 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.62839 | 29 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.6513 | 29 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.65453 | 29 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.62588 | 29 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.67481 | 30 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.66144 | 29 |